A Seminole mom is fighting for her son's health after a rare disorder left him dependent on a strict medical diet. But now, ...

The biochemist introduced the first heel-prick tests for newborn babies in Spain, protecting infants from life-changing ...

Introduction to Newborn Screening InstrumentsNewborn screening is a critical medical process that involves testing newborns for certain genetic, metabolic, and congenital conditions. The objective is ...

PTC Therapeutics (PTCT) saw its shares surge in the last session with trading volume being higher than average. The latest ...

PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...

The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go ...

Melissa Russell tells PEOPLE that while daughter Leah's peers are going off to college and starting their own lives, she found her own way to give her daughter, living with CHD2, a feel of her own ...

There’s also MZE782, an oral SCL6A19 inhibitor in a phase 1 trial with healthy volunteers and plans to pursue the drug in chronic kidney disease and phenylketonuria. From these raises ...

Under Emirates Health Services (EHS) theme "Future Health Now", EHS is participating in the 50th edition of Arab Health 2025, which kicks off tomorrow and runs until 30th January at the Dubai World ...

Genzyme Corp. (Sanofi Genzyme) has disclosed sodium-dependent neutral amino acid transporter B(0)AT1 (SLC6A19) inhibitors reported to be useful for the treatment of phenylketonuria, among others.